GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...

With the price of weight-loss injection Mounjaro rising by 170 per cent next month, we asked a pharmacist and medical ...

Four weeks after starting Mounjaro, Clare Meadowcroft was hospitalised for 10 days with acute pancreatitis and underwent ...

Scientists test OKV-119, a six-month implant dubbed 'Ozempup', as a new Ozempic for pets to fight obesity in cats and dogs amid rising pet health risks.

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions of dollars in lawsuits and growing concerns about long-term safety. Human ...

It's hard to read the news right now without another article about Ozempic popping up. The fat loss jab - originally ...

"When I am lying in bed waiting for an acute flare-up of nausea to subside, I feel so depressed that I can’t help wondering ...

In the world of fat activism, the “O-words” – overweight and obesity – are expressly verboten. That’s because advocates and ...